U.S. patent number D954,982 [Application Number D/747,032] was granted by the patent office on 2022-06-14 for covid immunoassay test device.
This patent grant is currently assigned to Hangzhou Biotest Biotech Co., LTD.. The grantee listed for this patent is Hangzhou Biotest Biotech Co., LTD. Invention is credited to Luna Hou, Zhenyu Wang, Chunsheng Ye, Zhenxing Zhang.
United States Patent |
D954,982 |
Ye , et al. |
June 14, 2022 |
COVID immunoassay test device
Claims
CLAIM The ornamental design for a COVID immunoassay test device, as
shown and described.
Inventors: |
Ye; Chunsheng (Hangzhou,
CN), Zhang; Zhenxing (Hangzhou, CN), Wang;
Zhenyu (Hangzhou, CN), Hou; Luna (Hangzhou,
CN) |
Applicant: |
Name |
City |
State |
Country |
Type |
Hangzhou Biotest Biotech Co., LTD |
Zhejiang |
N/A |
CN |
|
|
Assignee: |
Hangzhou Biotest Biotech Co.,
LTD. (Hangzhou, CN)
|
Appl.
No.: |
D/747,032 |
Filed: |
August 19, 2020 |
Foreign Application Priority Data
|
|
|
|
|
Jun 30, 2020 [CN] |
|
|
202030344244.8 |
|
Current U.S.
Class: |
D24/223 |
Current International
Class: |
2402 |
Field of
Search: |
;D24/107,121-123,216,217,219,223-227,229-232 ;D10/81
;D9/523,547,549,550,724,732 |
References Cited
[Referenced By]
U.S. Patent Documents
Other References
Researchers Applaud Spanish COVID-19 Serological Survey. Online,
published date May 28, 2020. Retrieved on Oct. 21, 2021 from URL:
https://www.the-scientist.com/news-opinion/researchers-applaud-spanish-co-
vid-19-serological-survey-67590. cited by examiner .
How Deadly Is COVID-19? New Stanford Study Raises as Many Questions
as It Answers. Online, published date Apr. 20, 2020. Retrieved on
Oct. 21, 2021 from URL:
https://www.extremetech.com/extreme/309500-how-deadly-is-covid--
19-new-stanford-study-raises-questions. cited by examiner.
|
Primary Examiner: Agilee; Omeed
Attorney, Agent or Firm: Nz Carr Law Office PLLC
Description
FIG. 1 is a front view of a COVID immunoassay test device according
to the present design;
FIG. 2 is a rear view of the COVID immunoassay test device of FIG.
1;
FIG. 3 is a left view of the COVID immunoassay test device of FIG.
1;
FIG. 4 is a right view of the COVID immunoassay test device of FIG.
1;
FIG. 5 is a top view of the COVID immunoassay test device of FIG.
1;
FIG. 6 is a bottom view of the COVID immunoassay test device of
FIG. 1;
FIG. 7 is a front perspective view of the COVID immunoassay test
device of FIG. 1; and,
FIG. 8 is a rear perspective view of the COVID immunoassay test
device of FIG. 1.
* * * * *
References